Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 89, Number 4, 1 April 2014

Mature results of MM‐011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma
pp. 349-354(6)
Authors: Lazaryan, Aleksandr; Hussein, Mohamad A.; Reu, Frederic J.; Faiman, Beth; Habecker, Becky; Ann Karam, Mary; Reed, Janice; Hamilton, Kimberly; Waksman, Joel; Bruening, Kellie; Srkalovic, Gordan; Andresen, Steven; Kalaycio, Matthew; Sweetenham, John W.; Sobecks, Ronald; Dean, Robert; Knight, Robert; Zeldis, Jerome B.; Baz, Rachid

Favourites:
ADD

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case‐matched study
pp. 355-362(8)
Authors: Morabito, Fortunato; Bringhen, Sara; Larocca, Alessandra; Wijermans, Pierre; Victoria Mateos, Maria; Gimsing, Peter; Mazzone, Carla; Gottardi, Daniela; Omedè, Paola; Zweegman, Sonja; José Lahuerta, Juan; Zambello, Renato; Musto, Pellegrino; Magarotto, Valeria; Schaafsma, Martijn; Oriol, Albert; Juliusson, Gunnar; Cerrato, Chiara; Catalano, Lucio; Gentile, Massimo; Isabel Turel, Ana; Marina Liberati, Anna; Cavalli, Maide; Rossi, Davide; Passera, Roberto; Rosso, Stefano; Beksac, Meral; Cavo, Michele; Waage, Anders; San Miguel, Jesus; Boccadoro, Mario; Sonneveld, Pieter; Palumbo, Antonio; Offidani, Massimo

Favourites:
ADD

Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies
pp. 363-368(6)
Authors: Minden, Mark D.; Hogge, Donna E.; Weir, Scott J.; Kasper, Jim; Webster, Debra A.; Patton, Lavonne; Jitkova, Yulia; Hurren, Rose; Gronda, Marcela; Goard, Carolyn A.; Rajewski, Lian G.; Haslam, John L.; Heppert, Kathleen E.; Schorno, Kevin; Chang, Hong; Brandwein, Joseph M.; Gupta, Vikas; Schuh, Andre C.; Trudel, Suzanne; Yee, Karen W. L.; Reed, Gregory A.; Schimmer, Aaron D.

Favourites:
ADD

Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters
pp. 369-374(6)
Authors: Raess, Philipp W.; Geijn, Gert‐Jan M.; Njo, Tjin L.; Klop, Boudewijn; Sukhachev, Dmitry; Wertheim, Gerald; McAleer, Tom; Master, Stephen R.; Bagg, Adam

Favourites:
ADD

Mutation analysis of a cohort of US patients with hemophilia B
pp. 375-379(5)
Authors: Li, Tengguo; Miller, Connie H.; Driggers, Jennifer; Payne, Amanda B.; Ellingsen, Dorothy; Hooper, W. Craig

Favourites:
ADD

Novel type of red blood cell pyruvate kinase hyperactivity predicts a remote regulatory locus involved in PKLR gene expression
pp. 380-384(5)
Authors: Oirschot, Brigitte Antoinette; Francois, Jerney Johanna Jeanette Maria; Solinge, Wouter Willem; Wesel, Annet Cornelia Wilhelmina; Rijksen, Gert; Amstel, Hans Kristian Ploos; Wijk, Richard

Favourites:
ADD

Erythropoiesis‐driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15
pp. 385-390(6)
Authors: Fertrin, Kleber Yotsumoto; Lanaro, Carolina; Franco‐Penteado, Carla Fernanda; Albuquerque, Dulcinéia Martins; Mello, Mariana Rezende Bandeira; Pallis, Flávia Rubia; Bezerra, Marcos André Cavalcanti; Hatzlhofer, Betania Lucena Domingues; Olbina, Gordana; Olalla Saad, Sara Terezinha; Silva Araújo, Aderson; Westerman, Mark; Costa, Fernando Ferreira

Favourites:
ADD

Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload
pp. 391-394(4)
Authors: Puliyel, Mammen; Sposto, Richard; Berdoukas, Vasilios A.; Hofstra, Thomas C.; Nord, Anne; Carson, Susan; Wood, John; Coates, Thomas D.

Favourites:
ADD

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high‐dose cytarabine‐based induction chemotherapy
pp. 395-398(4)
Authors: Jabbour, Elias; Daver, Naval; Champlin, Richard; Mathisen, Michael; Oran, Betul; Ciurea, Stefan; Khouri, Issa; Cornelison, A Megan; Ghanem, Hady; Cardenas‐ Turanzas, Marylou; Popat, Uday; Ravandi, Farhad; Giralt, Sergio; Garcia‐Manero, Guillermo; Cortes, Jorge; Kantarjian, Hagop; Lima, Marcos

Favourites:
ADD

Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse
pp. 399-403(5)
Authors: Pilorge, Sylvain; Rigaudeau, Sophie; Rabian, Florence; Sarkozy, Clémentine; Taksin, Anne L.; Farhat, Hassan; Merabet, Fathia; Ghez, Stéphanie; Raggueneau, Victoria; Terré, Christine; Garcia, Isabelle; Renneville, Aline; Preudhomme, Claude; Castaigne, Sylvie; Rousselot, Philippe

Favourites:
ADD

Factors associated with bronchiolitis obliterans syndrome and chronic graft‐versus‐host disease after allogeneic hematopoietic cell transplantation
pp. 404-409(6)
Authors: Gazourian, Lee; Rogers, Angela J.; Ibanga, Ruby; Weinhouse, Gerald L.; Pinto‐Plata, Victor; Ritz, Jerome; Soiffer, Robert J.; Antin, Joseph H.; Washko, George R.; Baron, Rebecca M.; Ho, Vincent T.

Favourites:
ADD

Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
pp. 410-416(7)
Authors: Thépot, Sylvain; Itzykson, Raphael; Seegers, Valerie; Recher, Christian; Raffoux, Emmanuel; Quesnel, Bruno; Delaunay, Jacques; Cluzeau, Thomas; Marfaing Koka, Anne; Stamatoullas, Aspasia; Chaury, Marie‐Pierre; Dartigeas, Caroline; Cheze, Stéphane; Banos, Anne; Morel, Pierre; Plantier, Isabelle; Taksin, Anne‐Laure; Marolleau, Jean Pierre; Pautas, Cecile; Thomas, Xavier; Isnard, Francoise; Beve, Blandine; Chait, Yasmine; Guerci, Agnes; Vey, Norbert; Dreyfus, Francois; Ades, Lionel; Ifrah, Norbert; Dombret, Herve; Fenaux, Pierre; Gardin, Claude; On behalf of the Groupe Francophone des Myélodysplasies (GFM), the Acute Leukemia French Association (ALFA); the Groupe Ouest‐Est des Leucémies Aiguës; Maladies du Sang (GOELAMS)ajh23654-cr-0032

Favourites:
ADD

Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein‐10 predicts inferior prognosis in untreated diffuse large B‐cell lymphoma
pp. 417-422(6)
Authors: Witzig, Thomas E.; Maurer, Matthew J.; Stenson, Mary J.; Allmer, Cristine; Macon, William; Link, Brian; Katzmann, Jerry A.; Gupta, Mamta

Favourites:
ADD

Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high‐grade myelodysplastic syndromes
pp. 423-428(6)
Authors: Buckley, Sarah A.; Othus, Megan; Vainstein, Vladimir; Abkowitz, Janis L.; Estey, Elihu H.; Walter, Roland B.

Favourites:
ADD

Follicular lymphoma: 2014 update on diagnosis and management
pp. 429-436(8)
Author: Freedman, Arnold

Favourites:
ADD

Azurophilic granules in myeloma cells
pp. 437-437(1)
Authors: Bain, Barbara J.; Siow, Wenchee; Rahemtulla, Amin; Abdalla, Saad

Favourites:
ADD

Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene
pp. 438-442(5)
Authors: Tiziana Storlazzi, Clelia; Pieri, Lisa; Paoli, Chiara; Daniele, Giulia; Lasho, Terra; Tefferi, Ayalew; Vannucchi, Alessandro M.

Favourites:
ADD

Haptoglobin testing in hemolysis: Measurement and interpretation
pp. 443-447(5)
Authors: Shih, Andrew W.Y.; McFarlane, Andrew; Verhovsek, Madeleine

Favourites:
ADD

Cutaneous involvement by post‐polycythemia vera myelofibrosis
pp. 448-448(1)
Authors: Pecci, Alessandro; Croci, Giorgio; Balduini, Carlo L.; Boveri, Emanuela

Favourites:
ADD

CD75: A B‐cell marker which should not be forgotten in lymphocyte predominant Hodgkin lymphoma
pp. 449-449(1)
Authors: Carbone, Antonino; Gloghini, Annunziata

Favourites:
ADD

CALR mutation studies in chronic neutrophilic leukemia
pp. 450-450(1)
Authors: Lasho, Terra L.; Elliott, Michelle A.; Pardanani, Animesh; Tefferi, Ayalew

Favourites:
ADD

Mortality from myelodysplastic syndromes: A multiple causes of death approach
pp. 450-451(2)
Authors: Fedeli, Ugo; Schievano, Elena; Saugo, Mario; Rodeghiero, Francesco

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more